• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

错构瘤蛋白与结节性硬化蛋白(TSC1和TSC2基因产物)之间的相互作用。

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.

作者信息

van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P

机构信息

MGC Department of Clinical Genetics, Erasmus University, 3015GE Rotterdam, The Netherlands.

出版信息

Hum Mol Genet. 1998 Jun;7(6):1053-7. doi: 10.1093/hmg/7.6.1053.

DOI:10.1093/hmg/7.6.1053
PMID:9580671
Abstract

Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by a mutation in either the TSC1 or TSC2 tumour suppressor gene. The disease is characterized by a broad phenotypic spectrum that can include seizures, mental retardation, renal dysfunction and dermatological abnormalities. TSC2 encodes tuberin, a putative GTPase activating protein for rap1 and rab5. The TSC1 gene was recently identified and codes for hamartin, a novel protein with no significant homology to tuberin or any other known vertebrate protein. Here, we show that hamartin and tuberin associate physically in vivo and that the interaction is mediated by predicted coiled-coil domains. Our data suggest that hamartin and tuberin function in the same complex rather than in separate pathways.

摘要

结节性硬化症(TSC)是一种常染色体显性疾病,由TSC1或TSC2肿瘤抑制基因的突变引起。该疾病具有广泛的表型谱,可包括癫痫发作、智力迟钝、肾功能障碍和皮肤异常。TSC2编码结节蛋白,一种推测的rap1和rab5的GTP酶激活蛋白。TSC1基因最近被鉴定出来,编码错构瘤蛋白,一种与结节蛋白或任何其他已知脊椎动物蛋白无显著同源性的新型蛋白。在这里,我们表明错构瘤蛋白和结节蛋白在体内发生物理结合,并且这种相互作用是由预测的卷曲螺旋结构域介导的。我们的数据表明,错构瘤蛋白和结节蛋白在同一复合物中发挥作用,而不是在单独的途径中。

相似文献

1
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.错构瘤蛋白与结节性硬化蛋白(TSC1和TSC2基因产物)之间的相互作用。
Hum Mol Genet. 1998 Jun;7(6):1053-7. doi: 10.1093/hmg/7.6.1053.
2
TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.TSC2错义突变抑制结节蛋白磷酸化并阻止结节蛋白-错构瘤蛋白复合物的形成。
Hum Mol Genet. 2001 Dec 1;10(25):2889-98. doi: 10.1093/hmg/10.25.2889.
3
Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.胞质结节性硬化蛋白-错构瘤蛋白复合物的特性。结节性硬化蛋白是错构瘤蛋白的一种胞质伴侣蛋白。
J Biol Chem. 1999 Dec 10;274(50):35647-52. doi: 10.1074/jbc.274.50.35647.
4
Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.TSC1和TSC2中的病理性突变破坏了错构瘤蛋白和结节性硬化蛋白之间的相互作用。
Hum Mol Genet. 2001 Dec 1;10(25):2899-905. doi: 10.1093/hmg/10.25.2899.
5
Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.结节蛋白磷酸化调节其与错构瘤蛋白的相互作用。这两种蛋白与结节性硬化症有关。
J Biol Chem. 2001 Jun 15;276(24):21017-21. doi: 10.1074/jbc.C100136200. Epub 2001 Apr 4.
6
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.结节性硬化症复合基因产物,即结节蛋白和错构瘤蛋白,通过作为Rheb的GTP酶激活蛋白复合物来控制mTOR信号传导。
Curr Biol. 2003 Aug 5;13(15):1259-68. doi: 10.1016/s0960-9822(03)00506-2.
7
Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.结节性硬化症基因产物在哺乳动物细胞周期调控中的可分离功能的证据。
J Neuropathol Exp Neurol. 2002 Feb;61(2):154-63. doi: 10.1093/jnen/61.2.154.
8
Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.14-3-3蛋白对结节性硬化复合物(TSC)功能的调节
Biochem Soc Trans. 2003 Jun;31(Pt 3):587-91. doi: 10.1042/bst0310587.
9
Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.对结节性硬化症患者中发现的TSC2终止密码子变体的分析。
Eur J Hum Genet. 2001 Nov;9(11):823-8. doi: 10.1038/sj.ejhg.5200728.
10
Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.结节性硬化症相关的血管纤维瘤中存在结节蛋白和错构瘤蛋白表达缺失,但散发性血管纤维瘤中不存在这种情况。
J Cutan Pathol. 2003 Mar;30(3):174-7. doi: 10.1034/j.1600-0560.2003.2o066.x.

引用本文的文献

1
Tuberous Sclerosis Complex: A Case Series from a Romanian Genetics Center and a Review of the Literature.结节性硬化症:来自罗马尼亚遗传学中心的病例系列及文献综述
J Clin Med. 2025 Apr 25;14(9):2974. doi: 10.3390/jcm14092974.
2
Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate.解析结节性硬化症复合物1-2(TSC1-TSC2)的功能:对干细胞命运的影响
Stem Cell Res Ther. 2025 Feb 4;16(1):38. doi: 10.1186/s13287-025-04170-3.
3
Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome.
人类TSC2突变细胞在早期神经发育中表现出异常,同时伴有DNA甲基化组的变化。
Hum Mol Genet. 2025 Apr 6;34(8):684-698. doi: 10.1093/hmg/ddae199.
4
Molecular chaperones: Guardians of tumor suppressor stability and function.分子伴侣:肿瘤抑制因子稳定性和功能的守护者。
Oncotarget. 2024 Oct 1;15:679-696. doi: 10.18632/oncotarget.28653.
5
Focusing on CD8 T-cell phenotypes: improving solid tumor therapy.聚焦 CD8 T 细胞表型:改善实体瘤治疗。
J Exp Clin Cancer Res. 2024 Sep 28;43(1):266. doi: 10.1186/s13046-024-03195-5.
6
Genotypic and phenotypic analysis of Korean patients with tuberous sclerosis complex.韩国结节性硬化症患者的基因型和表型分析。
Neurogenetics. 2024 Oct;25(4):471-479. doi: 10.1007/s10048-024-00777-5. Epub 2024 Aug 7.
7
IL-37d suppresses Rheb-mTORC1 axis independently of TCS2 to alleviate alcoholic liver disease.IL-37d 通过独立于 TCS2 的方式抑制 Rheb-mTORC1 轴来缓解酒精性肝病。
Commun Biol. 2024 Jun 21;7(1):756. doi: 10.1038/s42003-024-06427-8.
8
Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome.人类TSC2突变细胞在早期神经发育中表现出异常,同时伴有DNA甲基化组的变化。
bioRxiv. 2024 Jun 6:2024.06.04.597443. doi: 10.1101/2024.06.04.597443.
9
Contractile and Genetic Characterization of Cardiac Constructs Engineered from Human Induced Pluripotent Stem Cells: Modeling of Tuberous Sclerosis Complex and the Effects of Rapamycin.源自人类诱导多能干细胞的心脏构建体的收缩和遗传特征:结节性硬化症复合体的建模及雷帕霉素的作用
Bioengineering (Basel). 2024 Feb 28;11(3):234. doi: 10.3390/bioengineering11030234.
10
mTOR pathway - a potential therapeutic target in stroke.mTOR通路——中风的一个潜在治疗靶点。
Ther Adv Neurol Disord. 2023 Aug 9;16:17562864231187770. doi: 10.1177/17562864231187770. eCollection 2023.